A fourth dose of a Covid mRNA vaccine – Pfizer or Moderna – can increase immune defences beyond the peak immunity seen following a third dose, new research suggests.
The fourth dose of a Covid vaccine – sometimes known as the second booster – is currently available in the UK to those aged 75 or over, people living in care homes and those over the age of 12 who are immunosuppressed.
The study, from the COV-BOOST trial, which measured immune responses in 166 participants aged 50-80, found those who had received their fourth vaccine of Pfizer or Moderna had twice as many more antibodies as those who had received just their third vaccine.
Participants who had previously tested positive for Covid had high levels of immunity before the fourth vaccine, which was not boosted by the fourth vaccine.
Professor Saul Faust, director of the NIHR Southampton Clinical Research Facility and the trial lead, said the results ‘underline the benefits of the most vulnerable people receiving current spring boosters and give confidence for any prospective autumn booster programme in the UK, if the Joint Committee on Vaccination and Immunisation considers it needed at that time’.
Sajid Javid, the health secretary, added: ‘This is further evidence underlining the importance of people coming forward for their booster as soon as they are eligible.
‘We’re able to live with Covid thanks to the protection provided by our phenomenal vaccine programme and a booster dose will top up your immunity to continue to keep you and your loved ones safe.’
This means more than half - 2.8 million - of the 5.5 million people eligible for the jab by the end of June have so far been protected, according to figures from Thursday (5 May).
The NHS is inviting hundreds of thousands of people for their spring booster weekly, as more people become eligible, and is urging people to come forward as soon as they are eligible.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.